Clinical Trials Directory

Trials / Conditions / Cutaneous Squamous Cell Carcinoma of the Head and Neck

Cutaneous Squamous Cell Carcinoma of the Head and Neck

12 registered clinical trials studyying Cutaneous Squamous Cell Carcinoma of the Head and Neck — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingImpact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positiv
NCT07361666
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji—
RecruitingPhase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0),
NCT06990737
University of California, DavisPhase 2
RecruitingTowards Cure Via Only Ultra-short ICB in CSCC
NCT06823479
The Netherlands Cancer InstitutePhase 2
RecruitingRemote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a
NCT06662058
Emory UniversityN/A
TerminatedSurveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of
NCT05956795
Johns Hopkins University—
Active Not RecruitingDeep sequencIng in Cutaneous Squamous CEll caRciNomas
NCT05878288
Peter MacCallum Cancer Centre, AustraliaPhase 2
RecruitingNeoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
NCT05025813
Queensland HealthPhase 2
CompletedDecisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
NCT05482880
Maastricht University Medical Center—
Active Not RecruitingIntensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT
NCT05075980
Mayo ClinicPhase 2
Active Not RecruitingNeeds and Preferences of Patients With Head-neck Cutaneous SCC
NCT06046625
Maastricht University Medical Center—
TerminatedCemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
NCT04242173
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
Active Not RecruitingMagnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
NCT03491176
M.D. Anderson Cancer Center—